Viewing Study NCT04164459


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2025-12-25 @ 1:27 PM
Study NCT ID: NCT04164459
Status: UNKNOWN
Last Update Posted: 2019-11-15
First Post: 2019-10-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.
Sponsor: Taejoon Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module